Literature DB >> 17363070

Quality of life of 'normal' controls: association with lifetime history of mental illness.

Dianne Schechter1, Jean Endicott, John Nee.   

Abstract

This study assessed the perceived quality of life of individuals who were not in treatment for a psychiatric disorder and who were volunteers for a program to recruit control subjects. Subjects completed the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) and a diagnostic evaluation for lifetime history of mental disorders. Individuals were assigned to one of four categories according to the results of the diagnostic evaluation: Never Mentally Ill (NMI), one episode of a Minor Mental Disorder (MMD), Currently Not Mentally Ill with a serious history of mental illness (CNMI), and Currently Mentally Ill (CMI). Subjects in the two healthiest groups (NMI, MMD) reported the greatest life satisfaction and generally did not differ from each other. Subjects in the CNMI group reported significantly less satisfaction than subjects in the NMI and MMD groups, but greater life satisfaction than subjects who were currently mentally ill (CMI). The results demonstrate that an individual's current quality of life is strongly related to the extent of his or her history of mental illness. The findings provide the first available benchmarks for the Q-LES-Q for the degree of life satisfaction experienced by an untreated sample of individuals.

Entities:  

Mesh:

Year:  2007        PMID: 17363070      PMCID: PMC2291021          DOI: 10.1016/j.psychres.2006.09.008

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  25 in total

1.  Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.

Authors:  Uriel Halbreich; Richard Bergeron; Kimberly A Yonkers; Ellen Freeman; Anna L Stout; Lee Cohen
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

2.  Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis.

Authors:  Prabhat K Chand; Surendra K Mattoo; Pratap Sharan
Journal:  Psychiatry Clin Neurosci       Date:  2004-06       Impact factor: 5.188

3.  A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.

Authors:  Linda L Carpenter; Sarah Yasmin; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2002-01-15       Impact factor: 13.382

4.  "Normal" control subjects are hard to find: a model for centralized recruitment.

Authors:  D Schechter; T J Strasser; C Santangelo; E Kim; J Endicott
Journal:  Psychiatry Res       Date:  1994-09       Impact factor: 3.222

5.  Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.

Authors:  Lorrin M Koran; Elizabeth Hackett; Arkady Rubin; Robert Wolkow; Delbert Robinson
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

6.  Predictors of quality of life in major psychoses: a naturalistic follow-up study.

Authors:  Michael Ritsner; Rena Kurs; Anatoly Gibel; Shmuel Hirschmann; Evgeny Shinkarenko; Yael Ratner
Journal:  J Clin Psychiatry       Date:  2003-03       Impact factor: 4.384

7.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

8.  Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

Authors:  Michael R Liebowitz; Nicholas A DeMartinis; Karen Weihs; Peter D Londborg; Ward T Smith; Henry Chung; Rana Fayyad; Cathryn M Clary
Journal:  J Clin Psychiatry       Date:  2003-07       Impact factor: 4.384

9.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

10.  A diagnostic interview: the schedule for affective disorders and schizophrenia.

Authors:  J Endicott; R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1978-07
View more
  29 in total

1.  The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.

Authors:  Mark Hyman Rapaport; Andrew A Nierenberg; Robert Howland; Christina Dording; Pamela J Schettler; David Mischoulon
Journal:  J Psychiatr Res       Date:  2011-05-31       Impact factor: 4.791

2.  Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.

Authors:  W W IsHak; J Mirocha; D James; G Tobia; J Vilhauer; H Fakhry; S Pi; E Hanson; R Nashawati; E D Peselow; R M Cohen
Journal:  Acta Psychiatr Scand       Date:  2014-06-23       Impact factor: 6.392

3.  Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment.

Authors:  Enrique López; Alexander J Steiner; Karra Manier; Bryan B Shapiro; Brigitte Vanle; Thomas Parisi; Jonathan Dang; Tiffany Chang; Shaina Ganjian; James Mirocha; Itai Danovitch; Waguih William IsHak
Journal:  J Affect Disord       Date:  2017-08-14       Impact factor: 4.839

4.  Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V.

Authors:  Andrew A Nierenberg; Mark Hyman Rapaport; Pamela J Schettler; Robert H Howland; Juliana A Smith; Deidre Edwards; Trisha Schneider; David Mischoulon
Journal:  CNS Neurosci Ther       Date:  2010-03-04       Impact factor: 5.243

5.  Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.

Authors:  Emma Morton; Erin E Michalak; Anthony Levitt; Robert D Levitan; Amy Cheung; Rachel Morehouse; Rajamannar Ramasubbu; Lakshmi N Yatham; Edwin M Tam; Raymond W Lam
Journal:  Can J Psychiatry       Date:  2020-06-23       Impact factor: 4.356

6.  Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial.

Authors:  Becky Kinkead; Pamela J Schettler; Erika R Larson; Dedric Carroll; Margaret Sharenko; James Nettles; Sherry A Edwards; Andrew H Miller; Mylin A Torres; Boadie W Dunlop; Jeffrey J Rakofsky; Mark Hyman Rapaport
Journal:  Cancer       Date:  2017-10-17       Impact factor: 6.860

7.  Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight).

Authors:  Meryl Brod; Mette Hammer; Nana Kragh; Suzanne Lessard; Donald M Bushnell
Journal:  Health Qual Life Outcomes       Date:  2010-02-05       Impact factor: 3.186

8.  Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.

Authors:  Manish Kumar Jha; Abu Minhajuddin; Michael E Thase; Robin B Jarrett
Journal:  J Affect Disord       Date:  2014-06-02       Impact factor: 4.839

9.  Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.

Authors:  Antonella Benvenuti; Paola Rucci; Simona Calugi; Giovanni B Cassano; Mario Miniati; Ellen Frank
Journal:  Int Clin Psychopharmacol       Date:  2010-03       Impact factor: 1.659

10.  Validity and reliability of the Chinese version of the Short Form of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-SF).

Authors:  Yun-Tse Lee; Shen-Ing Liu; Hui-Chun Huang; Fang-Ju Sun; Chiu-Ron Huang; Albert Yeung
Journal:  Qual Life Res       Date:  2013-09-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.